Whalegun
Home

Mark Jeffrey DeLong, Chief Business & Strat Officer: Apellis Pharmaceuticals APLS Sell · Filed 24/01/23

Trade details

Type
Insider sale
Amount
$89,960
Shares · price
1,384 sh · $65.00 a share
Held after
65,570 sh
Stock
Apellis Pharmaceuticals APLS
Person
Mark Jeffrey DeLongChief Business & Strat Officer
Trade date
24/01/22
Filed
24/01/23
Days to filing
1 days

Sold 2.1% of holdings

Share of holding sold
2.1%

Apellis Pharmaceuticals trades, last 26 weeks

What else happened in Apellis Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/23~24/02/21

Mark Jeffrey DeLong's recent trades

  • Mark Jeffrey DeLong

    SellApellis Pharmaceuticals

    $8,151

    Filed 02/13

  • Mark Jeffrey DeLong

    SellApellis Pharmaceuticals

    $73.4K

    Filed 01/23

  • Mark Jeffrey DeLong

    SellApellis Pharmaceuticals

    $26.4K

    Filed 01/21

  • Mark Jeffrey DeLong

    SellApellis Pharmaceuticals

    $39.5K

    Filed 01/15

  • Mark Jeffrey DeLong

    SellApellis Pharmaceuticals

    $10.4K

    Filed 25/02/12